Accurate classification of echocardiographic views (e.g. apical 2- and 4-chamber, parasternal long-axis) is an important prerequisite for reliable ejection-fraction assessment and heart failure diagnosis, but manual classification is time-consuming. This study evaluates the EchoJ…
Voice characteristics are an emerging, non-invasive biomarker for heart failure. This study develops a machine learning pipeline to differentiate patients with suspected heart failure from those with a confirmed diagnosis using vocal features alone, drawing on 240 patients (50 su…
Accurate delineation of coronary arteries from X-ray angiography supports early identification of narrowing or blockages, but is complicated by low contrast and thin, branching vessel structures. This study compares three U-Net-based segmentation architectures — U-Net, U-Ne…
Echocardiographic assessment of End-Diastolic Volume (EDV) is central to identifying dilated cardiomyopathy, a major driver of heart failure. This paper presents a low-latency, edge-computing solution that deploys an 8-bit quantized, 50%-pruned CNN directly onto a Xilinx Artix-7…
Voice characteristics are an emerging, non-invasive biomarker for heart failure. This study develops a machine learning pipeline to differentiate patients with suspected heart failure from those with a confirmed diagnosis using vocal features alone, drawing on 240 patients (50 su…
Echocardiographic assessment of End-Diastolic Volume (EDV) is central to identifying dilated cardiomyopathy, a major driver of heart failure. This paper presents a low-latency, edge-computing solution that deploys an 8-bit quantized, 50%-pruned CNN directly onto a Xilinx Artix-7…
Accurate delineation of coronary arteries from X-ray angiography supports early identification of narrowing or blockages, but is complicated by low contrast and thin, branching vessel structures. This study compares three U-Net-based segmentation architectures — U-Net, U-Ne…
Distinguishing heart failure with reduced ejection fraction (HFrEF) from heart failure with preserved ejection fraction (HFpEF) is clinically important but challenging. This paper presents an end-to-end deep learning pipeline for automated three-class classification (healthy, HFr…
Heart failure presents with a wide range of symptoms that affect patients' quality of life. This study uses physical-examination data and blood biomarkers to predict the emergence of thirteen individual HF-related symptoms (e.g. dyspnea, orthopnea, peripheral oedema, pulmonary cr…
Heart failure is one of the most life-threatening diseases of the modern era, with high global mortality and morbidity rates, motivating the need for long-term outcome prediction. One established tool is the MAGGIC Risk Calculator for Heart Failure, which predicts 3-5 year mortal…
Morbidity and disease severity in heart failure are commonly assessed using New York Heart Association (NYHA) classes. This study uses non-invasive data — physical examination, symptoms and disease history — to classify patients into four morbidity classes approximati…
Heart failure and chronic obstructive pulmonary disease often present with overlapping clinical signs, making differential diagnosis challenging. This work applies machine learning, primarily random forest ensembles trained on heterogeneous clinical data (physical examination, bl…
Heart failure (HF) affects over 64.3 million people worldwide. As a part of the StratifyHF project, we developed a decision support system (DSS) to enhance HF prediction and diagnosis through machine learning (ML) approaches. The DSS comprises two modules: Early diagnosis and Ris…